日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Exploring options for family medicine subspecialisation in South Africa: A proposed way forward following a national workshop

探讨南非家庭医学亚专科发展方向：全国研讨会后提出的前进方向

期刊:
影响因子:
doi:10.4102/jcmsa.v3i1.258
Naidoo, Mergan; von Pressentin, Klaus; Muller, Madeleine; Omole, Olufemi; Suthiram, Kimera T; Baldwin-Ragaven, Laurel
发表日期：2025
文献求助 收藏

Tachykinin Receptor-Selectivity of the Potential Glioblastoma-Targeted Therapy, DOTA-[Thi(8),Met(O(2))(11)]-Substance P

潜在胶质母细胞瘤靶向治疗药物DOTA-[Thi(8),Met(O(2))(11)]-P物质的速激肽受体选择性

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms24032134
Suthiram, Janine; Pieters, Ané; Mohamed Moosa, Zulfiah; Zeevaart, Jan Rijn; Sathekge, Mike M; Ebenhan, Thomas; Anderson, Ross C; Newton, Claire L
信号转导
细胞生物学
发表日期：2023
文献求助 收藏

Towards Facile Radiolabeling and Preparation of Gallium-68-/Bismuth-213-DOTA-[Thi(8), Met(O(2))(11)]-Substance P for Future Clinical Application: First Experiences

为未来临床应用，开发简便的镓-68-/铋-213-DOTA-[Thi(8), Met(O(2))(11)]-P物质放射性标记和制备方法：初步经验

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics13091326
Suthiram, Janine; Ebenhan, Thomas; Marjanovic-Painter, Biljana; Sathekge, Mike M; Zeevaart, Jan Rijn
发表日期：2021
文献求助 收藏

Development of a Single Vial Kit Solution for Radiolabeling of 68Ga-DKFZ-PSMA-11 and Its Performance in Prostate Cancer Patients

68Ga-DKFZ-PSMA-11 放射性标记单瓶试剂盒溶液的开发及其在前列腺癌患者中的表现

期刊:Molecules
影响因子:4.2
doi:10.3390/molecules200814860
Thomas Ebenhan, Mariza Vorster, Biljana Marjanovic-Painter, Judith Wagener, Janine Suthiram, Moshe Modiselle, Brenda Mokaleng, Jan Rijn Zeevaart, Mike Sathekge
肿瘤
前列腺癌
发表日期：2015
文献求助 收藏

Tetra-ethyl-ammonium tricarbonyl-chlorido-(pyrazine-2-carboxyl-ato-N,O)rhenate(I).

四乙基铵三羰基氯化物-(吡嗪-2-羧酸-N,O)铼(I)

期刊:Acta Crystallographica Section E-Structure Reports Online
影响因子:0.6
doi:10.1107/S1600536809042160
Suthiram Janine, Mhlaba Kanyisa, Zeevaart Jan Rijn, Visser Hendrik G, Roodt Andreas
发表日期：2009
文献求助 收藏